Sun Pharma share price today declined 3.07% to Rs 1691.20 per share on Bombay Stock Exchange (BSE) as Sensex surged sharply by 2594.45 points to 82,048.92. The company informed today that its Board of Directors will hold meeting May 22, 2025 to consider financial results for the quarter ended March 31, 2025. The company will also consider and recommend final dividend, if any for FY 2024-25. Last trading price of Sun Pharmaceutical Industries Ltd shares declined 10.74% year-to-date as Sensex surged 4.59% and BSE Healthcare index slipped 8.67%.
The pharmaceuticals sector stock gained 11.99% in last 1-year and surged 76.54% in last 2-years. Meanwhile, the company has a market capitalisation of Rs 4,04, 589.99 crore. Its return on equity stood at 13.35%. FII/FPI holdings plunged from 18.04% to 17.96% for March 2025 quarter. Life Insurance Corporation Of India has 3.04% stake in Sun Pharma with 72,886,584 shares of the company. Check more details below:
Sun Pharma To Consider Financial Results, Dividend
The company via its exchange filing dated May 12, 2025 stated, “This is to inform that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 22 May 2025, inter alia, to,
1. Consider and approve Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2025.
2. Consider and recommend final dividend, if any, on the equity shares of the Company for FY 2024- 25, for approval of the shareholders at the ensuing Annual General Meeting.”
Sun Pharma Dividend History
The company recommended 29 dividends since 2002. In last 1-year, Sun Pharma announced an equity dividend of Rs 15.50 per share. At the current share price of Rs 1691.20, Sun Pharma offers a dividend yield of 0.91%, according to Trendlyne.
Sun Pharma Share Performance
The 52-week high of Sun Pharma share price on BSE is Rs 1960.20 per share (as on 30/09/2024) and 52-week low price is Rs 1376.75 per share (as on 04/06/2024), respectively. The stock slipped 8.08% in last 1-week, fell 6.28% in last 6-months, and surged 98.42% in last 3-years. The pharma stock delivered triple digit returns of 263.67% in last 5-years.
Why Sun Pharma Shares Have Been Falling?
Several pharma stocks witnessed steep fall on Monday, May 12, 2025 after US President Donald Trump shared his latest post on his social media network “Truth Social”. The President said that he is planning to sign an executive order on Monday at 9 AM Washington time that will reduce costs of prescription and pharmaceuticals drugs roughly 30% to 80% with immediate effect. Trump state he plans to institute a most favoured nations policy, whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World.” Healthcare costs in the US “will be reduced by numbers never even thought of before.”
Disclaimer: The story highlights dividend and should not be considered as investment advice by the Moneydaily.in or the Author. Moneydaily.in and the author will not be held responsible for any losses caused as a result of decisions based on the above information. Moneydaily.in advises readers to do their own research or consult a SEBI registered investment advisor before making any investment decisions.
Recommended: 270% Dividend: Tata Investment Reveals Dividend Payment Date, Shares Gain
Leave a Reply